Canada · Health Canada Drug Product Database

INFANRIX HEXA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
73878
DIN
02253852
Form
Suspension
Company as listed by source
GLAXOSMITHKLINE INC
Source status
Marketed (2008-12-04)
Source last updated
2025-03-22

Source-listed ingredients

  • DIPHTHERIA TOXOID — 25 LF — per 0.5 ML
  • TETANUS TOXOID — 10 LF — per 0.5 ML
  • PERTUSSIS TOXOID — 25 MCG — per 0.5 ML
  • FILAMENTOUS HAEMAGGLUTININ — 25 MCG — per 0.5 ML
  • PERTACTIN — 8 MCG — per 0.5 ML
  • HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) — 10 MCG — per 0.5 ML
  • POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED) — 40 UNIT — per 0.5 ML
  • POLIOVIRUS TYPE 2 MEF1 (INACTIVATED) — 8 UNIT — per 0.5 ML
  • POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED) — 32 UNIT — per 0.5 ML
  • HAEMOPHILUS INFLUENZAE TYPE B-PRP — 10 MCG — per 0.5 ML
  • TETANUS TOXOID ADSORBED — 40 MCG — per 0.5 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 10x0.5ml

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →